DU Y ET AL: "Human anti-beta-amyloid antibodies block beta-amyloid fibril formation and prevent beta-amyloid-induced neurotoxicity", BRAIN, OXFORD UNIVERSITY PRESS, OXFORD, GB, vol. 126, no. 9, September 2003 (2003-09), pages 1935-1939, XP002360367, ISSN: 0006-8950 (B1)

EP-A- 1 172 378 (B1)

GEYLIS ET AL: "Immunotherapy of Alzheimer's disease (AD): From murine models to anti-amyloid beta (Abeta) human monoclonal antibodies", AUTOIMMUNITY REVIEWS, ELSEVIER, AMSTERDAM, NL, vol. 5, no. 1, January 2006 (2006-01), pages 33-39, XP005203566, ISSN: 1568-9972 (B1)

GEYLIS V ET AL: "Human monoclonal antibodies against amyloid-beta from healthy adults", NEUROBIOLOGY OF AGING, TARRYTOWN, NY, US, vol. 26, no. 5, May 2005 (2005-05), pages 597-606, XP004748495, ISSN: 0197-4580 (B1)

HYMAN B T ET AL: "Autoantibodies to Amyloid-beta and Alzheimer's Disease", ANNALS OF NEUROLOGY, BOSTON, US, vol. 49, no. 6, 2001, pages 808-810, XP001030614, ISSN: 0364-5134 (B1)

WO-A-2006/103116 (B1)

SIMPSON J ET AL: "Autoantibodies to Alzheimer and normal brain structures from virus-transformed lymphocytes.", JOURNAL OF NEUROIMMUNOLOGY NOV 1986, vol. 13, no. 1, November 1986 (1986-11), pages 1-8, XP002430383, ISSN: 0165-5728 (B1)

US-A1- 2006 235 207 (B1)

WEKSLER M E ET AL: "Patients with Alzheimer disease have lower levels of serum anti-amyloid peptide antibodies than healthy elderly individuals", EXPERIMENTAL GERONTOLOGY, ELSEVIER SCIENCE, OXFORD, GB, vol. 37, no. 7, July 2002 (2002-07), pages 943-948, XP002903206, ISSN: 0531-5565 (B1)

WO-A-2005/018424 (B1)

SIMPSON J ET AL: "Antibodies to normal and Alzheimer human brain structures from non-immunised mice of various ages.", FEBS LETTERS 8 JUN 1987, vol. 217, no. 1, 8 June 1987 (1987-06-08), pages 62-64, XP002430384, ISSN: 0014-5793 (B1)